CD19 and lymphopenia: This lymphopenia affects the changes of B-cell phenotype heterogeneously, with a marked reduction of CD19+CD23+ (activated regulatory B cells) and CD19+CD5+ B cells (natural responder B1a cells), but normal numbers of CD19+CD69+ B cells (early activated B cells) (Monserrat et al., 2013).